Soccer Headers Might Be More Risky for APOE4 Genotype Carriers

Last Updated on

February 01, 2020 – Soccer headers might be more risky for APOE4 genotype carriers – this is the headline of a very recent Reuters Health article appearing in Medscape. Thus, soccer players with apolipoprotein E4 (APOE4) genotype may want to limit how many headers they do, as new research suggests an increased risk for memory problems with high levels of soccer heading in carriers of this common genetic risk factors for neurodegeneration.

The findings of a recent study published in JAMA Neurology provide a first indication that the APOE e4 allele may be associated with adverse cognitive sequelae of subconcussive repetitive head impacts (RHIs) independent of prior concussion, the study team reports. The senior author Dr. Michael Lipton from Albert Einstein College of Medicine, Bronx, New York, cautioned however, that there is not an immediate clinical implication to be expected. Rather, clinical implications might only appear eight to ten years after an individual experiences of repetitive mild traumatic brain injuries such as in chronic traumatic encephalopathy (CTE) as noted in other contact and high-impact sports such as boxing or American Football.

The findings in the present study are based on 352 adult amateur soccer players (mean age, 23 years; 256 men) enrolled in the longitudinal Einstein Soccer Study. They all played the game for more than five years and for more than six months per year. Every three to six months over about five years, players completed a validated, online questionnaire to estimate how many headers they did in a 12-month period that was categorized as low (165 headers per year; quartiles 1 and 2), moderate (638 per year; Q3), and high (2,346 headers per year; Q4).

Verbal memory was assessed at each study visit using the International Shopping List Delayed Recall (ISRL) task from CogState. Prior evidence had  suggested that the APOE e4 allele is associated with worse memory in healthy aging adults. high levels of heading were associated with significantly worse verbal-memory performance. And while there was no main association of APOE4 with verbal memory, there was a significant association of this genotype and soccer heading with performance on the ISRL task. In analyses stratified by APOE4 status, APOE4-positive players had about a fourfold greater deficit in verbal memory associated with high versus low heading exposure and an 8.5-fold greater deficit in verbal memory associated with high versus moderate heading exposure, compared with APOE4-negative players. The impairment was relatively mild, however. On an absolute scale, APOE4 carriers in the highest quartile of heading exposure recalled about one fewer item on the ISRL task compared with those in the other quartiles.

An Editorial in JAMA noted that given the observed impairment was subtle and that the study design was cross-sectional, it is unclear whether these impairments were associated with daily function, were noticed by the participants, or were transitory in nature. Conversely, that an interaction effect could be detected at all in a group of active players provides more credence to the modifying role of APOE e4 on repetitive head injury-cognition associations.

Nevertheless, as a father of  two boys who are completely into soccer, I might even today be inclined to have them tested for some risk genes in order to adapt their playing skills accordingly. See here what we potentially talk about:

[print friendly]

Tags: , , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion


No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Study of rare genetic disorder that effects the eyes April 3, 2020
    Nagano prefecture is home to a group of people affected with a rare genetic neurodegenerative disorder called familial amyloid polyneuropathies (FAP). This disease impacts the gene encoding protein transthyretin (TTR) which is produced in the liver and also eyes. Liver transplants are often a treatment for this disease, but severe eyesight problems such as cloudiness […]
  • Natural sunscreen gene influences how we make vitamin D April 2, 2020
    Genetic variations in the skin can create a natural sunscreen, according to University of Queensland researchers investigating the genes linked with vitamin D.
  • Single mutation leads to big effects in autism-related gene April 2, 2020
    A new study in Neuron offers clues to why autism spectrum disorder (ASD) is more common in boys than in girls. National Institutes of Health scientists found that a single amino acid change in the NLGN4 gene, which has been linked to autism symptoms, may drive this difference in some cases. The study was conducted […]
  • Lifestyle changes could delay memory problems in old age, depending on our genes April 2, 2020
    Researchers from King's College London have shown that how we respond to changes in nutrients at a molecular level plays an important role in the aging process, and this is directed by some key genetic mechanisms.
  • Geneticists are bringing personal medicine closer for multiracial individuals April 2, 2020
    A new study in Nature Communications proposes a method to extend polygenic scores, the estimate of genetic risk factors and a cornerstone of the personalized medicine revolution, to individuals with multiple ancestral origins. The study was led by Dr. Davide Marnetto from the Institute of Genomics of the University of Tartu, Estonia and coordinated by […]
  • Study of rare genetic disorder that effects the eyes April 3, 2020
    Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis.
  • Tissue dynamics provide clues to human disease April 3, 2020
    Scientists in EMBL Barcelona's Ebisuya group, with collaborators from RIKEN, Kyoto University, and Meijo Hospital in Nagoya, Japan, have studied oscillating patterns of gene expression, coordinated across time and space within a tissue grown in vitro, to explore the molecular causes of a rare human hereditary disease known as spondylocostal dysostosis. Their results are published […]
  • Coronavirus: Virological findings from patients treated in a Munich hospital April 3, 2020
    In early February, research teams from Charité - Universitätsmedizin Berlin, München Klinik Schwabing and the Bundeswehr Institute of Microbiology published initial findings describing the efficient transmission of SARS-CoV-2. The researchers' detailed report on the clinical course and treatment of Germany's first group of COVID-19 patients has now been published in Nature*. Criteria may now be […]
  • Case study: Treating COVID-19 in a patient with multiple myeloma April 3, 2020
    A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers. The report, published in Blood Advances, also suggests that blood cancer patients may have atypical COVID-19 symptoms.
  • Indigenous American ancestry may be associated with HER2-positive breast cancer April 3, 2020
    An increased proportion of Indigenous American (IA) ancestry was associated with a greater incidence of HER2-positive breast cancer, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.